Liabilities / Assets
33rd percentile
Higher debt load relative to assets than 33% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.10x
Liabilities / Revenue
44th percentile
Higher debt load relative to revenue than 44% of similar nonprofits.
Net Margin
18th percentile
Higher net margin than 18% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
12th percentile
Faster asset growth than 12% of similar nonprofits.
Revenue Growth
51st percentile
Faster revenue growth than 51% of similar nonprofits.
Balance Sheet
Assets
Down$12,375,250
Down $764,153 (-5.8%) from 2013
Net Assets
Down$11,144,258
Down $421,791 (-3.6%) from 2013
Liabilities
Down$1,230,992
Down $342,362 (-22%) from 2013
Revenue And Expenses
Revenue
Up$6,385,030
Up $295,485 (+4.9%) from 2013
Expenses
Up$6,806,821
Up $155,547 (+2.3%) from 2013
Net Income
Up-$421,791
Up $139,938 (+25%) from 2013
Historical Trend
Filing Detail Status
This 2014 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2014 to Dec 31, 2014
Mission and Program Overview
Mission
To provide a collaborative infrastructure to make progress in the prevention, diagnosis and treatment of sarcoma.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2014 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $12,375,250
- Liabilities
- $1,230,992
- Net assets
- $11,144,258
- Revenue
- $6,385,030
- Expenses
- $6,806,821
- Net income
- -$421,791